Data / Drug companies / Aphena Pharma Solutions - Tennessee, LLC
Aphena Pharma Solutions - Tennessee, LLC: 17 products in the FDA NDC directory, labeler code 67544
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Aphena Pharma Solutions - Tennessee, LLC (labeler code 67544) lists 17 products in the FDA National Drug Code Directory, covering 12 finished drugs by generic name. By type: 16 prescription drugs, 1 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on July 3, 2012.
The request: Watch Aphena Pharma Solutions - Tennessee, LLC (FDA labeler code 67544): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 67544
- Products in commercial distribution
- 17
- Packages
- 95
- Finished drugs by generic name
- 12
- Prescription products
- 16
- Over the counter products
- 1
- Controlled substance products
- Schedule III 2, Schedule IV 5
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- February 3, 1981
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 11 | 64.7% |
| Authorized generics (NDA) | 4 | 23.5% |
| New drug applications (NDA) | 2 | 11.8% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 16 | 94.1% |
| Over the counter drugs | 1 | 5.9% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Alprazolam | 3 | 37 |
| Acetaminophen and codeine phosphate | 2 | 24 |
| Paroxetine hydrochloride | 2 | 16 |
| Allopurinol | 2 | 54 |
| Guaifenesin | 1 | 123 |
| Prednisone | 1 | 49 |
| Spironolactone | 1 | 45 |
| Clonazepam | 1 | 36 |
| Temazepam | 1 | 28 |
| Baclofen | 1 | 65 |
| Hydralazine hydrochloride | 1 | 47 |
| Hydrochlorothiazide | 1 | 51 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 11 | 64.7% |
| Tablet, film coated | 3 | 17.6% |
| Tablet, extended release | 1 | 5.9% |
| Capsule | 1 | 5.9% |
| Capsule, gelatin coated | 1 | 5.9% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Mucinex | 67544-149 | Tablet, extended release | New drug applications (NDA) | July 3, 2012 |
| Acetaminophen and codeine phosphate | 67544-003 | Tablet | Generic drugs (ANDA) | July 6, 2011 |
| Acetaminophen and codeine phosphate | 67544-002 | Tablet | Generic drugs (ANDA) | July 6, 2011 |
| Allopurinol | 67544-313 | Tablet | New drug applications (NDA) | April 6, 2009 |
| Baclofen | 67544-671 | Tablet | Generic drugs (ANDA) | August 30, 2005 |
| Paroxetine | 67544-492 | Tablet, film coated | Generic drugs (ANDA) | September 8, 2003 |
| Paroxetine | 67544-317 | Tablet, film coated | Generic drugs (ANDA) | September 8, 2003 |
| Prednisone | 67544-399 | Tablet | Generic drugs (ANDA) | July 12, 2002 |
| Hydrochlorothiazide | 67544-739 | Capsule, gelatin coated | Authorized generics (NDA) | December 27, 1996 |
| Clonazepam | 67544-529 | Tablet | Generic drugs (ANDA) | September 18, 1996 |
| Hydralazine Hydrochloride | 67544-657 | Tablet | Generic drugs (ANDA) | September 30, 1990 |
| Temazepam | 67544-136 | Capsule | Generic drugs (ANDA) | August 3, 1987 |
| Allopurinol | 67544-736 | Tablet | Generic drugs (ANDA) | October 24, 1986 |
| Alprazolam | 67544-415 | Tablet | Authorized generics (NDA) | October 16, 1981 |
| Alprazolam | 67544-414 | Tablet | Authorized generics (NDA) | October 16, 1981 |
| Alprazolam | 67544-347 | Tablet | Authorized generics (NDA) | October 16, 1981 |
| Spironolactone | 67544-310 | Tablet, film coated | Generic drugs (ANDA) | February 3, 1981 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.